Life Science Company
Akorn has acquired 5 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 3 assets.
Akorn’s largest acquisition to date was in 2013, when it acquired Hi-Tech Pharmacal for $640M. It’s largest disclosed sale occurred in 2021, when it sold Akorn - Consumer Health Business to Prestige Consumer Healthcare for $230M. Akorn has acquired in 4 different US states. The Company’s most targeted sectors include life science (40%) and medical products (40%).
Join Mergr and gain access to Akorn’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity8
- M&A Buy Activity5
- M&A Sell Activity3
- Total Sectors Invested 3
- Total Countries Invested 1
- M&A Buy/Sell Connections 7
- M&A Advisors 5
Unlimited Searches
